1-(5-Fluoropyridin-2-yl)piperazine dihydrochloride

Catalog No. :
ACSTOJ182
CAS No. :
1955547-02-0
Molecular Formula :
C9H14Cl2FN3
Molecular Weight :
254.14

IUPAC Name:1-(5-fluoropyridin-2-yl)piperazine dihydrochloride

1-(5-Fluoropyridin-2-yl)piperazine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$167.00Login to see priceInquiryInquiry
250mg95%$248.00Login to see priceInquiryInquiry
1g95%$496.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Fluoropyridin-2-yl)piperazine dihydrochloride
IUPAC Name1-(5-fluoropyridin-2-yl)piperazine dihydrochloride
MDL No.MFCD28891465
Molecular FormulaC9H14Cl2FN3
Molecular Weight254.14
SMILESFC1=CN=C(N2CCNCC2)C=C1.[H]Cl.[H]Cl
InChI KeyNIONQJYXPBFCKX-UHFFFAOYSA-N
Synonym1-(5-fluoropyridin-2-yl)piperazine dihydrochloride;Piperazine, 1-(5-fluoro-2-pyridinyl)-, hydrochloride (1:2)
CAS No.1955547-02-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSTOJ182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACGLUR087 route compound structure diagram
    ACGLUR08741404-58-4 In Stock
  4. Then
  5. ACSTOJ182 route product structure diagram
    ACSTOJ1821955547-02-0
Inquiry

2. ACSTOJ182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSTOJ182 route product structure diagram
    ACSTOJ1821955547-02-0
Inquiry

Comments (0)